StockWatch
·
Biotechnology: Pharmaceutical Preparations
RegulatoryJun 12, 2026, 09:01 AM

Cuprina Regains Nasdaq Compliance; Delisting Hearing Cancelled

AI Summary

Cuprina Holdings announced it has regained compliance with the Nasdaq Capital Markets Listing Requirements, specifically the minimum bid price rule. The company had previously received a delisting determination letter and appealed the decision. As a result of regaining compliance, the hearing before the Nasdaq Hearing Panel, scheduled for July 7, 2026, has been cancelled, and the company's shares will continue to trade on Nasdaq.

Key Highlights

  • Cuprina Holdings regained compliance with Nasdaq Capital Markets Listing Requirements on June 11, 2026.
  • The company previously faced delisting for failing the $1.00 minimum bid price requirement.
  • A hearing before the Nasdaq Hearing Panel, scheduled for July 7, 2026, has been cancelled.
  • Cuprina's Class A Ordinary Shares will continue to be listed on The Nasdaq Capital Market under "CUPR".